U.S. Pharma Stock News

NasdaqGS:DWSN
NasdaqGS:DWSNEnergy Services

Dawson Geophysical (DWSN) Returns To Quarterly Profit Challenging Volatility‑Focused Narratives

Dawson Geophysical (DWSN) closed out FY 2025 with fourth quarter revenue of US$26.9 million and basic EPS of US$0.02, alongside net income of US$0.6 million. This set a cleaner finish to a year where the trailing twelve month figures still show a loss of US$1.9 million on US$75.6 million of revenue and a basic EPS loss of US$0.06. Over recent quarters the company has seen quarterly revenue range from US$9.9 million to US$26.9 million, with EPS moving between a loss of US$0.08 and a profit of...
NasdaqGS:SIMO
NasdaqGS:SIMOSemiconductor

Silicon Motion Targets Auto Grade NAND To Balance AI And PC Cycles

Silicon Motion Technology (NasdaqGS:SIMO) is expanding its automotive grade NAND storage controller portfolio for connected and AI focused vehicles. The company is aligning products with automotive safety and cybersecurity standards such as AEC-Q100, ISO 26262, ISO 21434, and ASPICE Level 3. Its embedded storage solutions are being tailored for advanced driver-assistance systems and autonomous driving platforms. For readers following NasdaqGS:SIMO, this push into automotive storage sits on...
NasdaqGS:ALKS
NasdaqGS:ALKSBiotechs

Alkermes Narcolepsy Trials Spark Interest In Growth And Valuation Upside

Alkermes (NasdaqGS:ALKS) has begun Phase 3 clinical trials for alixorexton, its orexin 2 receptor agonist for narcolepsy type 1 and type 2. The late stage Brilliance Studies aim to evaluate alixorexton in patients with significant unmet treatment needs in sleep disorders. This marks a new development in Alkermes' pipeline beyond prior focus areas highlighted in earlier coverage. For Alkermes, known for its work in neuroscience and psychiatry, the Brilliance Studies add a new dimension to...
NasdaqGM:JFIN
NasdaqGM:JFINConsumer Finance

Does Jiayin Group’s (JFIN) Bigger Dividend And Buyback Hint At A Strategic Capital Shift?

Jiayin Group Inc. has reported its fourth-quarter and full-year 2025 results, showing quarterly revenue of CNY 1,090.2 million and net income of CNY 100.63 million, alongside full-year revenue of CNY 6,222.19 million and net income of CNY 1,535.74 million. Alongside these results, the company increased its dividend payout framework to target around 30% of prior-year net income and completed a share repurchase of 4,600,000 shares, equal to 8.6% of its share count, signaling a stronger focus...
NYSE:MKC
NYSE:MKCFood

McCormick (MKC) Margin Surge To 23.1% Challenges Bearish Profitability Narratives

McCormick (MKC) opened fiscal 2026 with Q1 revenue of US$1,873.9 million and basic EPS of US$3.78, set against trailing twelve month revenue of US$7.1 billion and EPS of US$6.12, where earnings over the last year were reported as up 109.4%. Over recent quarters the company has seen revenue move from US$1,605.5 million in Q1 2025 to US$1,850.4 million in Q4 2025 and then to US$1,873.9 million in Q1 2026. Quarterly EPS tracked from US$0.60 to roughly the mid US$0.80 range before the latest step...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Exploring Three High Growth Tech Stocks In The US Market

The United States market remained flat over the last week but has seen a 16% increase over the past year, with earnings anticipated to grow by 15% annually in the coming years. In this context, identifying high growth tech stocks involves looking for companies that not only demonstrate strong innovation and scalability but also align well with these promising market conditions.
NYSE:YUM
NYSE:YUMHospitality

Yum Brands Board Refresh And Store Closures Refocus Growth Priorities

Yum! Brands appointed former Marriott CFO Kathleen (Leeny) K. Oberg to its Board of Directors, adding extensive global finance and hospitality experience. The company plans to close 250 underperforming Pizza Hut locations under its Hut Forward plan. Yum! Brands is transferring 20 Taco Bell outlets in Australia to a new operator, signaling a reset of parts of its international footprint. Yum! Brands (NYSE:YUM) is trading at $155.48, with a value score of 2 and a mixed return profile that...
NasdaqGS:EA
NasdaqGS:EAEntertainment

Electronic Arts’ Index Exit Amid Rising EPS Estimates Could Be A Game Changer For Electronic Arts (EA)

In March 2026, Electronic Arts Inc was removed from the NASDAQ Internet Index, even as the company reported strong year-over-year EPS and revenue growth. Analysts have since raised their earnings estimates for EA, suggesting the index removal coincided with improving confidence in the company’s underlying profitability profile. With analyst earnings estimates moving higher, we’ll now examine how this renewed business momentum reshapes Electronic Arts’ broader investment narrative. The...
NYSE:CNM
NYSE:CNMTrade Distributors

Core And Main Governance Shift Puts New Utility Expertise To Work

Core & Main (NYSE:CNM) has appointed former American Water Works CEO M. Susan Hardwick to its board, effective April 1. The company has restructured key governance roles, including a new board chair and a new audit committee chair. The longstanding executive chair has retired as part of the succession changes. Core & Main, trading at $49.4, is adjusting its leadership structure after a 3-year return of 121.8% and a 1-year return of 0.0%. The share price has seen a 2.3% decline over the past...
NasdaqCM:OCGN
NasdaqCM:OCGNBiotechs

Ocugen Hits Key Milestone In GARDian3 Stargardt Gene Therapy Program

Ocugen (NasdaqCM:OCGN) completed enrollment and dosing early in its pivotal Phase 2/3 GARDian3 trial for OCU410ST. The trial evaluates a one time gene therapy candidate for Stargardt disease, a severe inherited retinal disorder with no approved treatments. This is Ocugen's second late stage clinical program and aligns with its stated goal to submit multiple BLAs by 2028. For readers tracking gene therapy names, Ocugen sits at the intersection of rare ophthalmology and inherited retinal...
NasdaqGM:VERA
NasdaqGM:VERABiotechs

Vera Therapeutics Adds Experienced Legal Chief As Shares Trade Below Targets

Vera Therapeutics has appointed Jane Wright-Mitchell as its new Chief Legal Officer. Wright-Mitchell brings extensive legal, compliance, and intellectual property experience in life sciences and pharmaceuticals. The appointment adds senior leadership depth as Vera Therapeutics continues to develop its pipeline. The new Chief Legal Officer steps in at a time when Vera Therapeutics, listed as NasdaqGM:VERA, is trading at $40.23. The share price reflects a mixed return profile, with a 1.2%...
NYSE:SUI
NYSE:SUIResidential REITs

Is Sun Communities (SUI) Offering A Compelling Valuation After Recent Share Price Pullback?

If you are wondering whether Sun Communities at around US$125.96 is offering fair value right now, you are not alone, many investors are asking the same question. The stock’s recent returns have been mixed, with a 2.2% decline over the last week, a 7.7% decline over the last month, but a 3.1% gain year to date and 4.8% over the past year. These moves come as Sun Communities continues to attract attention as a Residential REIT, with investors weighing its track record over the last 3 and 5...
NasdaqGS:FSUN
NasdaqGS:FSUNBanks

FirstSun Index Exit Raises Questions On Liquidity And Undervalued Shares

FirstSun Capital Bancorp (NasdaqGS:FSUN) has been removed from the Russell 2000 Defensive Index. The company has also been dropped from the Russell 2500 Defensive, Russell 2500 Value-Defensive, and Russell 2000 Value-Defensive indices. This index reclassification affects how some passive and rules based funds may hold or view the stock. FirstSun Capital Bancorp, the holding company for FirstBank, operates as a regional banking platform focused on commercial and consumer financial services...
NYSE:TJX
NYSE:TJXSpecialty Retail

TJX Dividend Hike And Buybacks Set Against Premium Valuation Concerns

TJX Companies (NYSE:TJX) announced a 13% increase in its quarterly dividend. This is the 29th dividend increase approved by the Board in the past 30 years. The company reaffirmed plans to repurchase up to US$2.75b of shares during Fiscal 2027. TJX Companies, the off price retailer behind T.J. Maxx, Marshalls and HomeGoods, is signaling confidence through higher cash returns to shareholders. A 13% dividend increase and a reinforced buyback plan highlight how management is choosing to deploy...
NYSE:SNX
NYSE:SNXElectronic

TD SYNNEX (SNX) EPS Surge Tests Bullish Margin Expansion Narrative In Q1 2026

TD SYNNEX (SNX) opened fiscal 2026 with Q1 revenue of US$17.2b and basic EPS of US$4.09, setting the tone against a trailing twelve month backdrop of US$65.1b in revenue and US$12.06 in EPS. Over the past year, revenue has moved from US$58.5b to US$65.1b on a trailing basis, while EPS over the same window has shifted from US$7.99 to US$12.06. This provides a clear view of how the top and bottom lines have tracked into this latest quarter. For investors, the key question now is how sustainably...
NasdaqGS:SHOP
NasdaqGS:SHOPIT

Exploring 3 High Growth Tech Stocks In The US Market

In the last week, the United States market has stayed flat but is up 16% over the past year, with earnings forecasted to grow by 15% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for sustained revenue and earnings expansion in alignment with these broader market trends.
NYSE:KVYO
NYSE:KVYOSoftware

3 Insider-Owned Growth Companies With Up To 81% Earnings Expansion

In the last week, the United States market has stayed flat, yet it has risen by 16% over the past year with expectations of a 15% annual earnings growth in the coming years. In this context, identifying growth companies with high insider ownership can be advantageous as they often align management interests with shareholder value and may capitalize on favorable market conditions.
NYSE:SNAP
NYSE:SNAPInteractive Media and Services

3 Penny Stocks With Market Caps Under $19B To Watch

The market remained flat over the last week, but it is up 16% over the past year, with earnings expected to grow by 15% annually in the coming years. For those interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—can still offer surprising value and potential for growth. By focusing on stocks with strong financial foundations, investors may find opportunities that combine stability with promising prospects.
NasdaqCM:ESEA
NasdaqCM:ESEAShipping

Top Dividend Stocks To Consider In April 2026

Over the last 7 days, the United States market has remained flat, though it has experienced a robust 16% increase over the past year, with earnings expected to grow by 15% per annum in the coming years. In this context of steady growth and positive earnings projections, dividend stocks that offer consistent payouts and potential for capital appreciation can be an attractive option for investors seeking reliable income streams.
NYSE:MSCI
NYSE:MSCICapital Markets

MSCI Shifts Greece To Developed Market And Deepens ADR Index Reach

MSCI (NYSE:MSCI) plans to reclassify Greece from Emerging Market to Developed Market status in its equity indexes. The company is also partnering with Syntax Data to expand its ADR index offerings for financial advisers in the US. These changes affect how global capital is allocated to Greek equities and how advisers access international exposure through US listed securities. MSCI is best known for its global equity indexes that many asset managers and ETFs use as benchmarks, so its country...